Cardiovascular toxicity of illicit anabolic-androgenic steroid use
Long-term AAS use was associated with myocardial dysfunction and coronary atherosclerosis.
Observational; exposure self-selected.
Original source ↗Loading TrenasCycles…
TrenasCycles
Loading TrenasCycles…
Anabolic-androgenic steroid
drostanolone
Masteron is mainly a harder, drier-look drug, not a big size or scale-weight builder. The sharper look people report is most noticeable when they are already lean. It is not a fat burner or a reliable treatment for high estrogen. Main downsides are acne, faster hair loss if you are prone to it, worse cholesterol and suppressed natural testosterone.
Historical oncology studies establish androgenic drug activity, not modern bodybuilding efficacy or safety.
Androgenic hair/skin effects, virilization, gonadal suppression, unfavorable lipids and broader AAS cardiovascular risk.
HDL/LDL/triglycerides; blood pressure; liver enzymes; CBC; reproductive hormones; androgenic hair/skin effects.
Older human studies evaluated metastatic breast cancer; it is not an approved physique-enhancement treatment.
Other aliases: drostanolone · drostanolone propionate
Long-term AAS use was associated with myocardial dysfunction and coronary atherosclerosis.
Observational; exposure self-selected.
Original source ↗Documents historical antitumor/androgenic use.
Old oncology context; not physique evidence.
Original source ↗